|
National Stock Number(NSN): 6505-01-304-7216 (6505013047216, 013047216)
| NIIN: |
01-304-7216 |
Item Name: |
OCTREOTIDE ACETATE INJECTION |
INC: |
42303
|
| FSC: |
6505
|
Assignment Date: |
Jul-26-1989 |
CRIT: |
X |
IIG: |
42303 |
| ISC: |
2 |
Date Standardized: |
Jul-26-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.39.0050 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-0519 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00078-0180-03 |
04520
|
NOVARTIS PHARMACEUTICALS CORPORATION |
H |
3 |
2 |
4 |
KX |
|
|
|
|
|
|
|
SANDOSTATIN |
04520
|
NOVARTIS PHARMACEUTICALS CORPORATION |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
H |
|
Q |
U |
1 |
A |
$55.76 |
PG |
|
C2201X- |
Oct-01-2000 |
H |
| DF |
S9M |
H |
|
Q |
U |
1 |
F |
$55.76 |
PG |
|
------- |
Oct-01-2000 |
H |
| DM |
S9M |
Y |
Z |
Q |
U |
1 |
M |
$55.76 |
PG |
|
13M2--1 |
Dec-01-2000 |
H |
| DN |
SMS |
Y |
|
Q |
U |
1 |
N |
$55.76 |
PG |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
Q |
U |
1 |
D |
$55.76 |
PG |
|
------- |
Dec-01-2000 |
H |
| DS |
SMS |
Y |
|
Q |
U |
1 |
I |
$55.76 |
PG |
|
------- |
Dec-01-2000 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 20EA |
000 |
|
|
|
| DA |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 20EA |
000 |
|
|
|
| DF |
R |
REFER TO EDI ITEM |
000 |
|
|
|
| DM |
K |
U/I CONTAINS 20EA |
000 |
|
|
|
| DM |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 20EA |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 20EA |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 20 EA |
000 |
|
|
|
| DS |
V |
DISCONTINUED WITHOUT REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
0.050 MILLIGRAMS OCTREOTIDE ACETATE ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
AMPUL |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
1.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
20 |
| FEAT |
SPECIAL FEATURES |
EACH AMPUL SHALL ALSO CONTAIN; 2.000 MG ACETIC ACID,GLACIAL,USP; 2.000 MG SODIUM ACETATE TRIHDRATE,USP; 7.000 MG SODIUM CHLORIDE,USP; AND WATER FOR IRRIGATION,USP; ACETIC ACID,AND SODIUM ACETATE TRIHYDRATE ARE ADDED TO PROVIDE A BUFFERED SOLUTION,PH 4.2 PORM 0.3; SINGLE DOSE AMPULS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
3 |
Z |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|